Cours Ocera Therapeutics Inc

Actions

02/11/17	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders
20/10/17	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®
23/08/17	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017
01/08/17	Ocera Therapeutics Reports Second Quarter 2017 Financial Results
01/06/17	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	Varia.	Varia. 5j.	Varia. 1an	Varia. 3ans	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2,29%	-	-	0
REGENERON PHARMACEUTICALS, INC.	+3,22%	+10,02%	+29,32%	-3,33%	70,75 Md
UCB	-13,51%	-10,70%	+17,04%	+169,50%	54,35 Md
SAMSUNG BIOLOGICS CO.,LTD.	+3,25%	+52,70%	+52,70%	+52,70%	47,19 Md
CSL LIMITED	-0,11%	+8,47%	-52,97%	-52,04%	42,48 Md
BIOGEN INC.	-1,43%	+3,14%	+63,39%	-23,42%	30,91 Md
INCYTE CORPORATION	-3,75%	+5,18%	+58,27%	+92,62%	25,76 Md
MODERNA, INC.	+3,95%	-0,64%	+76,22%	-51,85%	21,62 Md
INNOVENT BIOLOGICS, INC.	-1,78%	-4,50%	-11,86%	+140,71%	19,91 Md
BRIDGEBIO PHARMA, INC.	-2,50%	-1,82%	+78,48%	+132,56%	16,33 Md
Moyenne	-1,26%	+2,98%	+34,51%	+50,83%	36,59 Md
Moyenne pondérée par Capi.	-1,48%	+3,96%	+28,52%	+44,82%